Leaving group
|
WikiDoc Resources for Leaving group | |
|
Articles | |
|---|---|
|
Most recent articles on Leaving group Most cited articles on Leaving group | |
|
Media | |
|
Powerpoint slides on Leaving group | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Leaving group at Clinical Trials.gov Trial results on Leaving group Clinical Trials on Leaving group at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Leaving group NICE Guidance on Leaving group
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Leaving group Discussion groups on Leaving group Patient Handouts on Leaving group Directions to Hospitals Treating Leaving group Risk calculators and risk factors for Leaving group
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Leaving group | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
A leaving group is an atom or group of atoms that detaches from a chemical substance. The remaining molecule or fragment remaining is known as the residual or main part. The term leaving group is dependent on the context of the statement.[1]
The ability for a functional group to leave is called lability. Leaving groups affect the intrinsic reactivity, not the nucleophilic discrimination factors.
The lower the pKa of the conjugate acid, the better the leaving group. This is because the lower the pKa of the conjugate acid of the leaving group, the more it stays in its anion (l.g.'s may be neutral), leaving group, form. This anion stability means that the leaving group is less likely to react with the cation formed by the leaving group's absence (this is the case with bad leaving groups). Without stabilization, a leaving group will become a nucleophile due to its negative charge, and if this happens, the reaction goes in circles. This is why a strong base is a poor leaving group. SN1 reactions prefer halides, pseudohalides, and non-coordinating ions as leaving groups. Halide salts are particularly useful leaving groups because they can be abstracted by silver ions, to form insoluble silver halides.
In room temperature water, the sequence of lability is:
- Less lability
- amine NH2−
- methoxy CH3O−
- hydroxyl HO−
- carboxylate CH3COO−
- F−
- water
- Cl−
- Br−
- I−
- azide N3−
- thiocyanate SCN−
- nitro NO2
- Greater Lability
- NO3 is also weaker than F−.
A direct application of the difference in leaving group stability is in the carboxylic acid derivatives. The worse the leaving group, the more stable the chemical, which makes these form a hierarchy that can be separated in the lab. Amines, which are the worst leaving group, are the most stable compound, and attacking any carboxylic acid derivative with an amine produces an amide. Esters are the second most stable followed by anhydrides and finally halides.
During the SN2 nucleophilic attack, a partial negative charge forms on the leaving group. During SN1 reactions, the leaving group anionizes and leaves. In general, amine, methoxy and hydroxyl groups never act as leaving groups in a substitution reaction.
In the non-mechanistic transformations, leaving group is the actual substituent group present in the substrate and product.
The structure of the leaving group affects the rates of both Sn1 and Sn2 reactions. In general, the more stable the leaving group is as a free species--that is after it has left--the faster it will leave. This stability also reflects the basicity of the species: the more stable it is, the weaker base it is.
See also
References
- ↑ International Union of Pure and Applied Chemistry. "leaving group". Compendium of Chemical Terminology Internet edition.
External links
- Strength: Bluffton College
WikiDoc Research Resources for Leaving group | |
|---|---|
| Articles on Leaving group | Most recent articles on Leaving group • Most cited articles on Leaving group • Review articles on Leaving group • Articles on Leaving group in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Leaving group | Powerpoint slides on Leaving group • Images of Leaving group • Photos of Leaving group • Podcasts & MP3s on Leaving group • Videos on Leaving group |
| Evidence Based Medicine Regarding Leaving group | AND (Cochrane Database Syst Rev[http://worldselectshop.com/?id=9361 Cochrane Collaboration on Leaving group • Bandolier on Leaving group • TRIP on Leaving group |
| Cost Effectiveness of Leaving group | AND (Cost effectiveness) |
| group5 = Clinical Trials Involving Leaving group | list5 = Ongoing Trials on Leaving group at Clinical Trials.gov • Trial results on Leaving group • Clinical Trials on Leaving group at Google
| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Leaving group
| list6 = US National Guidelines Clearinghouse on Leaving group • NICE Guidance on Leaving group • NHS PRODIGY Guidance • FDA on Leaving group • CDC on Leaving group
| group7 = Textbook Information on Leaving group
| list7 = Books and Textbook Information on Leaving group
| group8 = Pharmacology Resources on Leaving group
| list8 =
AND (Dose)}} Dosing of Leaving group • AND (drug interactions)}} Drug interactions with Leaving group • AND (side effects)}} Side effects of Leaving group • AND (Allergy)}} Allergic reactions to Leaving group • AND (overdose)}} Overdose information on Leaving group • AND (carcinogenicity)}} Carcinogenicity information on Leaving group • AND (pregnancy)}} Leaving group in pregnancy • AND (pharmacokinetics)}} Pharmacokinetics of Leaving group •
| group9 = Genetics, Pharmacogenomics, and Proteinomics of Leaving group
| list9 =
AND (pharmacogenomics)}} Genetics of Leaving group • AND (pharmacogenomics)}} Pharmacogenomics of Leaving group • AND (proteomics)}} Proteomics of Leaving group
| group10 = Newstories on Leaving group
| list10 = Leaving group in the news • Be alerted to news on Leaving group • News trends on Leaving group</small>
| group11 = Commentary on Leaving group
| list11 =
Blogs on Leaving group
| group12 = Patient Resources on Leaving group | list12 = Patient resources on Leaving group • Discussion groups on Leaving group • Patient Handouts on Leaving group • Directions to Hospitals Treating Leaving group • Risk calculators and risk factors for Leaving group
| group13 = Healthcare Provider Resources on Leaving group
| list13 =
Symptoms of Leaving group • Causes & Risk Factors for Leaving group • Diagnostic studies for Leaving group • Treatment of Leaving group
| group14 = Continuing Medical Education (CME) Programs on Leaving group | list14 = CME Programs on Leaving group
| group15 = International Resources on Leaving group | list15 = Leaving group en Espanol • Leaving group en Francais
| group16 = Business Resources on Leaving group | list16 = Leaving group in the Marketplace • Patents on Leaving group
| group17 = Informatics Resources on Leaving group | list17 = List of terms related to Leaving group
}}
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies